These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8497808)

  • 1. Repeated administration of Sigma ligands alters the population activity of rat midbrain dopaminergic neurons.
    Zhang J; Chiodo LA; Wettstein JG; Junien JL; Freeman AS
    Synapse; 1993 Mar; 13(3):223-30. PubMed ID: 8497808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of sigma receptors in the modulation of the glutamatergic/NMDA neurotransmission in the dopaminergic systems.
    Gronier B; Debonnel G
    Eur J Pharmacol; 1999 Mar; 368(2-3):183-96. PubMed ID: 10193654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
    Wachtel SR; White FJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
    Minabe Y; Matsuno K; Ashby CR
    Synapse; 1999 Aug; 33(2):129-40. PubMed ID: 10400891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of diphenylpyrazolidinone cholecystokinin-B and cholecystokinin-A antagonists on midbrain dopamine neurons.
    Rasmussen K; Czachura JF; Stockton ME; Howbert JJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):480-8. PubMed ID: 8423546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons.
    Zhang J; Chiodo LA; Wettstein JG; Junien JL; Freeman AS
    Synapse; 1992 Aug; 11(4):267-78. PubMed ID: 1323882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
    Bergeron R; de Montigny C; Debonnel G
    Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1985 Sep; 5(9):2539-44. PubMed ID: 2863337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K; Suzuki K; McCreary AC; Ashby CR
    Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
    Blackburn TP; Suzuki K; Ashby CR
    Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y; Emori K; Ashby CR
    Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
    Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low and high doses of selective sigma ligands: further evidence suggesting the existence of different subtypes of sigma receptors.
    Bergeron R; Debonnel G
    Psychopharmacology (Berl); 1997 Feb; 129(3):215-24. PubMed ID: 9084059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
    Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning.
    Debonnel G; Bergeron R; Monnet FP; De Montigny C
    Neuroscience; 1996 Apr; 71(4):977-87. PubMed ID: 8684626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
    Monnet FP; Debonnel G; Bergeron R; Gronier B; de Montigny C
    Br J Pharmacol; 1994 Jun; 112(2):709-15. PubMed ID: 8075892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands.
    Bermack JE; Debonnel G
    Br J Pharmacol; 2001 Oct; 134(3):691-9. PubMed ID: 11588125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.
    Chiodo LA; Bunney BS
    J Neurosci; 1983 Aug; 3(8):1607-19. PubMed ID: 6135762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.